Chemotherapy-free treatments: are we ready for prime time?
Ann Oncol
.
2019 Apr 1;30(4):497-498.
doi: 10.1093/annonc/mdz079.
Authors
D Lorusso
1
,
S Pignata
2
,
A Gonzalez-Martin
3
Affiliations
1
Fondazione Policlinico Universitario A Gemelli IRCCS, Rome. Electronic address: Domenica.lorusso@policlinicogemelli.it.
2
Istituto Nazionale Tumori di Napoli Fondazione Pascale, Naples, Italy.
3
Medical Oncology Department, Clinica Universidad de Navarra, Madrid, Spain.
PMID:
30835275
DOI:
10.1093/annonc/mdz079
No abstract available
Publication types
Editorial
Comment
MeSH terms
Female
Humans
Neoplasm Recurrence, Local
Ovarian Neoplasms*
Phthalazines
Piperazines
Platinum*
Progression-Free Survival
Quinazolines
Time
Substances
Phthalazines
Piperazines
Quinazolines
Platinum
cediranib
olaparib